Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Bioavailability of the Tablet Formulation (a Randomised, Open-label, Single Dose, Three-way Crossover Trial in Healthy Subjects)
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2014
Price : $35 *
At a glance
- Drugs BI 187004 CL (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 10 Oct 2014 Last checked against ClinicalTrials.gov record.
- 07 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.